Stock LGND LIGAND PHARMACEUTICALS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Ligand Pharmaceuticals Incorporated

Equities

LGND

US53220K5048

Market Closed - Nasdaq
Other stock markets
 21:00:00 08/05/2024 BST 		5-day change 1st Jan Change
80.36 USD +9.75% Intraday chart for Ligand Pharmaceuticals Incorporated +12.52% +12.52%
05-08 Sector Update: Health Care Stocks Softer Late Afternoon MT
05-08 Ligand Pharmaceuticals Shares Rise After Q1 Adjusted Earnings, Revenue Beat Views MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sector Update: Health Care Stocks Softer Late Afternoon
MT
Ligand Pharmaceuticals Shares Rise After Q1 Adjusted Earnings, Revenue Beat Views
MT
Earnings Flash (LGND) LIGAND PHARMACEUTICALS INCORPORATED Posts Q1 Revenue $31M, vs. Street Est of $27.9M
MT
Earnings Flash (LGND) LIGAND PHARMACEUTICALS INCORPORATED Reports Q1 EPS $1.20, vs. Street Est of $0.83
MT
Ligand Pharmaceuticals Incorporated Reaffirms Earnings Guidance for the Year 2024
CI
Sector Update: Health Care Stocks Stronger in Tuesday Afternoon Trading
MT
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
MT
Ligand Pharmaceuticals Incorporated Announces New Topiram Injection Data Presented At 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
CI
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics
CI
Ligand Pharmaceuticals' Q4 Adjusted Earnings Rise, Revenue Falls; Reaffirms 2024 Guidance
MT
Ligand Pharmaceuticals Incorporated Re-Affirms Earnings Guidance for 2024
CI
Earnings Flash (LGND) LIGAND PHARMACEUTICALS INCORPORATED Reports Q4 Revenue $28.1M, vs. Street Est of $25.7M
MT
Earnings Flash (LGND) LIGAND PHARMACEUTICALS INCORPORATED Reports Q4 EPS $1.05, vs. Street Est of $0.66
MT
Ligand Pharmaceuticals Incorporated Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Global markets live: Merck, Honda, Novartis, Boeing, Nvidia...
Our Logo
Ligand Pharmaceuticals Secures FDA Approval for Viral Skin Infection Medication; Shares Jump Premarket
MT
Ligand Pharmaceuticals Gets FDA OK for Viral Skin Infection Treatment
DJ
Ligand Pharma's at-home skin treatment gets FDA approval
RE
Ligand Pharmaceuticals Secures FDA Approval for Viral Skin Infection Medication
MT
Ligand Pharma's topical skin drug gets US FDA approval
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LGND Stock
  4. News Ligand Pharmaceuticals Incorporated
  5. Highlights